Browsing by Author Csoszi, Tibor

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trialHui, Rina; Brahmer, Julie; Csoszi, Tibor; Cuffe, SinEad; Deitz, Anne; Fulop, Andrea; Gottfried, Maya; Hotta, Katsuyuki; Lubiniecki, Gregory; O'Brien, Mary; Peled, Nir; Rangwala, Reshma; Rao, Suman; Reck, Martin; Robinson, Andrew; Rodriguez-Abreu, Delvys; Tafreshi, Ali; Zhang, Jin; Westmead Clinical School: MedicineHealth-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial, The Lancet Oncology, vol.18, 12, 2017,pp 1600-1609
2016Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung CancerHui, Rina; Csoszi, Tibor; Cuffe, SinEad; et al, Various; Fulop, Andrea; Gottfried, Maya; Peled, Nir; Reck, Martin; Robinson, Andrew; Rodriguez-Abreu, Delvys; Tafreshi, Ali; Western Clinical School: Medicine (Westmead)Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer, The New England Journal of Medicine, vol.375, 19, 2016,pp 1823-1833
2017Population Pharmacokinetics of Liposomal Irinotecan in Patients With CancerWong, Ka (Mark); Adiwijaya, B. S.; Chen, J. S.; Csoszi, Tibor; Cubillo, A.; et al, Various; Kim, J.; Kim, J. S.; Lang, Istvan; Park, J. O.; Rau, Kunming; Westmead Clinical School: MedicinePopulation Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer, Clinical Pharmacology & Therapeutics, vol.102, 6, 2017,pp 997-1005